ODDB.org: Open Drug Database

Swissmedic Registration	66795	Date of registration	01.11.2019
Company name	Pierre Fabre Pharma SA	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Braftovi 50 mg	Hartkapseln	Capsules (Encorafenibum 50 mg)	L01EC03	CI
02	Braftovi 75 mg	Hartkapseln	Capsules (Encorafenibum 75 mg)	L01EC03

2025	©ywesee GmbH